Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)
Clinical trial NCT05551598 · COMPLETED
Trial details
- NCT number
- NCT05551598
- Sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-28
- Primary completion
- 2024-07-18
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.